Alvotech (NASDAQ:ALVOW – Get Free Report) is expected to issue its resultson Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.0470) per share and revenue of $109.6360 million for the quarter.
Alvotech Price Performance
NASDAQ:ALVOW opened at $0.21 on Monday. Alvotech has a fifty-two week low of $0.15 and a fifty-two week high of $3.00. The business has a 50 day moving average price of $0.29 and a 200-day moving average price of $0.61.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Recommended Stories
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
